Man­u­fac­tur­ing tweaks to sub­cu­ta­neous Tecen­triq de­lay Roche's US launch, CMC process­es to be up­dat­ed by year’s end

Roche in­formed its drug de­liv­ery tech part­ner Halozyme Ther­a­peu­tics that the US launch of the sub­cu­ta­neous ver­sion of Tecen­triq will be de­layed to next year …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER